Publications

Sort by: Date | Author | Title

Rasmussen, M., Sunde, L., Nielsen, M. L., Ramsing, M., Petersen, A., Hjortshøj, T. D., Olsen, T. E., Tabor, A., Hertz, J. M., Johnsen, I., Sperling, L. S., Petersen, O. B., Jensen, U. B., Petersen, M. B. & Lildballe, D. L. (2016). Fetal Kidney Anomalies: Next Generation Sequencing. Abstract from European Society of Human Genetics Conference 2016, Barcelona, Spain.
Robinson, E. B., St Pourcain, B., Anttila, V., Kosmicki, J. A., Bulik-Sullivan, B., Grove, J., Maller, J., Samocha, K. E., Sanders, S. J., Ripke, S., Martin, J., Hollegaard, M. V., Werge, T., Hougaard, D. M., Neale, B. M., Evans, D. M., Skuse, D., Mortensen, P. B., Børglum, A. D. ... Als, T. D. (2016). Genetic risk for autism spectrum disorders and neuropsychiatric variation in the general population. Nature Genetics, 48(5), 552–555. https://doi.org/10.1038/ng.3529
Røder, M. E., Storgaard, H., Rungby, J., Knop, F. K. & Vilsbøll, T. (2016). Sodium-glucose cotransporter 2 (SGLT-2) inhibitors for patients with Type 2 diabetes. Ugeskrift for Læger, 178(38).
Roos, J., Vorup-Jensen, T., Matrone, C., Maier, T. J. & et al. (2016). On the role of lipoxygenases in pathogenesis of cancer. Progress in inflammation research (submitted after invitation), Lipoxygenases in Inflammation, Progress in Inflammation Research, DOI 10.1007/978-3-319-27766-0_7.
Roos, J., Grösch, S., Werz, O., Schröder, P., Ziegler, S., Fulda, S., Paulus, P., Urbschat, A., Kühn, B., Maucher, I., Fettel, J., Vorup-Jensen, T., Piesche, M., Matrone, C., Steinhilber, D., Parnham, M. J. & Maier, T. J. (2016). Regulation of tumorigenic Wnt signaling by cyclooxygenase-2, 5-lipoxygenase and their pharmacological inhibitors: A basis for novel drugs targeting cancer cells? Pharmacology & Therapeutics, 157, 43-64. https://doi.org/10.1016/j.pharmthera.2015.11.001